Patients | Controls | P value | |
---|---|---|---|
Serum | |||
IL-10 (pg/ml) | 2.3 (1.2–3.9) | 1.65 (0.54–2.9) | 0.0003a |
TGF-β (ng/ml) | 11.3 (3.5–164.1) | 7.8 (1.8–26.2) | 0.0005a |
VEGF (pg/ml | 614 (14–1374) | 210 (17–712) | 0.0004a |
TNF-α (ng/ml) | 15.9 (4.9–39.1) | 12.9 (10.4–19.5) | 0.1397 |
Saliva | |||
IL-10 (pg/ml) | 5.9 (2.9–12.7) | 2.5 (0.45–5.1) | 0.00002a |
TGF-β (ng/ml) | 24.1 (7–87.9) | 14.8 (5.4–30.1) | 0.00002a |
VEGF (pg/ml) | 4321 (1566–7791) | 280 (130–980) | 0.0000a |
TNF-α (ng/ml) | 23.1 (15.8–26.0) | 11.3 (8.2–17.7) | 0.00002a |